Business Description
CELLUMED Co Ltd
ISIN : KR7049180003
Compare
Compare
Traded in other countries / regions
049180.Korea IPO Date
2002-05-23Description
CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.27 | |||||
| Beneish M-Score | -4.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -157.6 | |||||
| 3-Year FCF Growth Rate | -27 | |||||
| 3-Year Book Growth Rate | -12.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.84 | |||||
| 9-Day RSI | 75.41 | |||||
| 14-Day RSI | 72.63 | |||||
| 6-1 Month Momentum % | 43.42 | |||||
| 12-1 Month Momentum % | -20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 27.14 | |||||
| Days Sales Outstanding | 55.7 | |||||
| Days Payable | 29.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.4 | |||||
| Shareholder Yield % | -6.73 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 10.42 | |||||
| Operating Margin % | -3.42 | |||||
| Net Margin % | -27.04 | |||||
| FCF Margin % | -7.35 | |||||
| ROE % | -84.33 | |||||
| ROA % | -37.06 | |||||
| ROIC % | -6.3 | |||||
| 3-Year ROIIC % | -103.55 | |||||
| ROC (Joel Greenblatt) % | -329.06 | |||||
| ROCE % | -72.24 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.67 | |||||
| PB Ratio | 6.74 | |||||
| Price-to-Tangible-Book | 7.4 | |||||
| EV-to-EBIT | -7.16 | |||||
| EV-to-EBITDA | -7.68 | |||||
| EV-to-Revenue | 1.88 | |||||
| EV-to-FCF | -18.91 | |||||
| Price-to-Median-PS-Value | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 23.31 | |||||
| Earnings Yield (Greenblatt) % | -13.95 | |||||
| FCF Yield % | -3.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CELLUMED Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 111,866.555 | ||
| EPS (TTM) (â‚©) | -700 | ||
| Beta | 1.14 | ||
| Volatility % | 99.72 | ||
| 14-Day RSI | 72.63 | ||
| 14-Day ATR (â‚©) | 391.707939 | ||
| 20-Day SMA (â‚©) | 3047.8 | ||
| 12-1 Month Momentum % | -20 | ||
| 52-Week Range (â‚©) | 1351 - 4415 | ||
| Shares Outstanding (Mil) | 50.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CELLUMED Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CELLUMED Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
CELLUMED Co Ltd Frequently Asked Questions
What is CELLUMED Co Ltd(XKRX:049180)'s stock price today?
The current price of XKRX:049180 is â‚©4140.00. The 52 week high of XKRX:049180 is â‚©4415.00 and 52 week low is â‚©1351.00.
When is next earnings date of CELLUMED Co Ltd(XKRX:049180)?
The next earnings date of CELLUMED Co Ltd(XKRX:049180) is .
Does CELLUMED Co Ltd(XKRX:049180) pay dividends? If so, how much?
CELLUMED Co Ltd(XKRX:049180) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers